You are here

  • Home
  • Archive
  • Volume 3, Issue 2
  • Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis

Citation Tools

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Juge P, Gazal S, Constantin A, et al
Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis
RMD Open 2017;3:e000448. doi: 10.1136/rmdopen-2017-000448